Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | UNK | — | — |
Patient had a "palsy-like" reaction at 6 months of age after receiving ACTHIB and VAXELIS; Patient had a "palsy-like" reaction at 6 months of age after receiving ACTHIB and VAXELIS; This non-serious spontaneous, safety report was received by partner on 08-APR-2025 and forwarded on 09-APR-2025 from a healthcare professional. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events; "Patient had a "palsy-like" reaction at 6 months of age after receiving ACTHIB and VAXELIS", and overdose. Further information is expected. SIGNIFICANT FOLLOW-UP INFORMATION was received on 24-APR-2025 from a healthcare professional (clinical manager). The healthcare professional reported that both Vaxelis and ACTHIB were not administered together at the same time. She further noted that the patient had reaction ("palsy-like" reaction) to Vaxelis, or Prevnar, or Rota according to the patient's mother. The reported was not able to confirm the reaction nor provide any further information as the event occurred while under the care of a previous pediatrician and there was no documentation was received from previous pediatrician. The reporter did not provide an assessment of the causal relationship between Vaxelis and the reported events; "Patient had a "palsy-like" reaction at 6 months of age after receiving ACTHIB and VAXELIS", and overdose. No further information is expected.
Prophylaxis
PREVENAR; ROTAVIRUS VACCINE